Related by context. All words. (Click for frequent words.) 82 Stroke Scale NIHSS 64 NIH CPSI 62 BMI z 62 APACHE II 61 SGRQ 61 Glasgow Coma Scale 61 CHADS2 60 Health Assessment Questionnaire 60 NYHA functional class 60 PSQI 59 Montgomery Åsberg Depression 59 Visual Analogue Scale VAS 59 Crohn Disease Activity 59 Rating Scale MADRS 59 PANSS total 59 Global Impression CGI 58 Fibromyalgia Impact Questionnaire 58 PHQ 9 57 HRQoL 57 ADCS CGIC 57 Brief Psychiatric 57 ADAS Cog 57 Coronary artery calcium 57 HAMD 57 State Examination MMSE 57 Y BOCS 57 Acute Physiology 57 NIHSS 56 EQ 5D 56 Wechsler Adult 56 WOMAC pain 56 YMRS 56 subscore 56 MMSE scores 56 DAS# [002] 56 QIDS SR 56 HOMA IR 56 NIHSS score 56 IBDQ 56 subclinical atherosclerosis 56 WOMAC 56 Index CDAI 56 subscale scores 56 Scale PANSS 56 ADAS cog 56 Symptom Severity 55 hemoglobin A1c levels 55 Common Toxicity Criteria 55 MADRS 55 depressive symptom 55 DAS# CRP 55 oxygen desaturation 55 UPDRS 55 Primary endpoints 55 intima media thickness 55 MMSE 55 SELENA SLEDAI 55 HAQ DI 55 Severity Index PASI 55 Status Scale EDSS 55 HADS 55 Depression Inventory 54 nasal symptom 54 symptomatic intracerebral hemorrhage 54 MMSE score 54 symptom severity 54 CHADS 54 Symptom severity 54 CFQ R 54 brachial artery flow 54 autonomic dysfunction 54 Common Terminology Criteria 54 Montgomery Asberg Depression 54 Disease Activity 54 Skin sterol 54 Ocular Surface Disease 54 Inventory BPI 54 preoperative PSA 54 SF #v# 54 CDAI 54 Unified Parkinson Disease 54 KCCQ 54 CaPSURE 54 subscores 54 underwent coronary angiography 54 biopsy Gleason 54 Ishak fibrosis score 54 Severity Index 54 logistic regression analysis 54 Neuropsychiatric Inventory 54 intracerebral haemorrhage 54 meta regression 54 exhaled NO 53 DAS# scores 53 Rating Scale UPDRS 53 Depressive symptoms 53 subtests 53 Myocardial Infarction TIMI 53 Symptom Checklist 53 mTSS 53 PANSS 53 OSDI 53 lowest tertile 53 Beck Anxiety Inventory 53 apnea hypopnea index 53 multivariable adjusted 53 VFQ 53 CNS LS 53 UPDRS motor 53 Injury Severity Score 53 CHADS 2 53 cTnT levels 53 subscales 53 Alzheimer Disease Assessment 53 Thrombolysis 53 HAM D 53 Oswestry Disability Index 53 MSLT 53 NSTEMI 53 Charlson Comorbidity Index 53 NYHA classification 53 leukocyte count 53 Rating Scale BPRS 53 Score DAS 53 HAM D# 53 Scale Cognitive Subscale 53 BILAG 53 carotid IMT 53 actigraphy 52 Afib 52 coronary calcium 52 LV dysfunction 52 DLQI 52 abnormal cytology 52 euthymic patients 52 Bonferroni correction 52 erythrocyte sedimentation rate 52 HDRS 52 Expanded Disability Status 52 interobserver reliability 52 Epworth Sleepiness Scale 52 albumin excretion rate 52 retest reliability 52 Clinician Administered PTSD 52 ankle brachial 52 Functional Assessment 52 p = .# [001] 52 glycated hemoglobin HbA1c 52 Negative Syndrome 52 NNT = 52 PERMP 52 intima media thickness IMT 52 Severity Scale 52 Erectile Function 52 inflammatory biomarkers 52 Stent thrombosis 52 Ashworth Scale 52 comorbid anxiety 52 BPH symptom 52 Erectile Function IIEF 52 salivary cortisol 52 ALS Functional 52 daytime dozing 52 IPSS 52 multivariate Cox 52 coronary stenosis 52 HEDIS R 52 multiple logistic regression 52 nonfasting triglyceride levels 52 HbA 1c levels 52 Interrater reliability 52 Patient Registry 52 dyssynchrony 52 prognostic variables 52 State Exam MMSE 52 Apgar scores 52 Depression Inventory BDI 52 IRLS 52 conditional logistic regression 52 FACIT Fatigue 52 multivariate logistic regression 52 Glomerular filtration rate 52 intelligence quotient IQ 52 Mania Rating Scale 52 psychosocial functioning 52 depressive symptomatology 52 Brief Pain 52 interrater reliability 52 electron beam computed tomography 52 Visual Analog 52 electrophysiologic 52 Scale EDSS 52 International Prostate Symptom 52 International Prognostic Scoring 52 coronary artery calcium 51 orthostatic 51 pretest probability 51 morphometric vertebral fractures 51 multivariable analysis 51 Endothelial function 51 HRQL 51 subjective sleepiness 51 bronchial hyperresponsiveness 51 clinically meaningful improvements 51 postoperative complication 51 SYNTAX 51 cortical atrophy 51 #q# deletion syndrome 51 carotid artery narrowing 51 odds ratios ORs 51 Non inferiority 51 Dr. Spiera 51 carotid stenosis 51 SRBD 51 HbA 1c 51 spirometric 51 nonfatal myocardial infarction MI 51 recurrent venous thromboembolism 51 stratifying patients 51 Negative Symptoms 51 DQI 51 WISC IV 51 Outcome Measures 51 nondiabetics 51 diabetes mellitus DM 51 polysomnogram 51 habitual snoring 51 Neuropsychiatric Inventory NPI 51 bivariate analyzes 51 hsCRP levels 51 troponin T 51 intracranial stenosis 51 silent myocardial ischemia 51 Global Impression Severity 51 adenotonsillectomy 51 carotid atherosclerosis 51 Distress Scale 51 subtest 51 glycated hemoglobin levels 51 Edinburgh Postnatal Depression 51 pressure monitoring ABPM 51 Nutrition Examination Surveys NHANES 51 coronary calcification 51 poststroke 51 clinically meaningful improvement 51 Visual Analog Scale 51 echocardiographic parameters 51 carotid ultrasound 51 Heritability 51 Scale cognitive subscale 51 warfarin dosage 51 Hamilton Rating Scale 51 total cholesterol triglycerides 51 covariate 51 MADRS score 50 Rating Scale 50 initiating antiretroviral therapy 50 PLMS 50 NPRS 50 Global Impression 50 hsCRP 50 CDAI score 50 psychosocial variables 50 Autistic Disorder 50 femoral neck BMD 50 Pain Rating Scale 50 Echocardiographic 50 diastolic pressures 50 IRLS score 50 Carotid Revascularization Endarterectomy vs. 50 P = .# 50 logistic regression analyzes 50 Secondary efficacy endpoints 50 erection hardness 50 Depression Scale 50 neurodevelopmental impairment 50 Neurocognitive 50 CC genotype 50 CIN2 + 50 FRAX 50 PSA nadir 50 Treatment Outcome 50 cerebral oxygenation 50 Psoriasis Area 50 Severity MSCS score 50 artery calcification 50 procalcitonin 50 CI -#.# 50 glycated hemoglobin 50 anemia hemoglobin 50 Risk Stratification 50 QRISK 50 Preoperatively 50 LVEF 50 tertiles 50 exhaled nitric oxide 50 Secondary endpoints included 50 Hemoglobin A1c 50 Intervention Trial 50 glomerular filtration rate 50 intraobserver 50 Comorbidity 50 Mini Mental 50 affective psychosis 50 ANCOVA 50 Epidemiological Studies Depression 50 estimated GFR 50 Healthy Behavior 50 Wechsler Intelligence 50 ADHD RS 50 Symptom Score 50 confirmed CCyR 50 cardio respiratory fitness 50 Prognostic Index 50 diastolic blood pressures 50 FDG PET scans 50 nonfasting 50 macroalbuminuria 50 lymphocyte count 50 Visual acuity 50 metabolic syndrome MetS 50 perinatal outcomes 50 Secondary endpoints include 50 hemoglobin A1c HbA1c 50 hemoglobin A1c 50 mRS 50 lactate dehydrogenase LDH 50 pulmonary capillary wedge 50 nondiabetic patients 50 neurobehavioral functioning 50 prespecified secondary 50 arterial thickening 50 HRQOL 50 postoperative delirium 50 GWTG CAD 50 diastolic readings 50 dactylitis 50 QTcF 50 plasma homocysteine 50 elevated bilirubin 50 hypertension diabetes mellitus 50 mL/min/#.# m 2 50 Maslach Burnout Inventory 50 visceral adiposity 50 extrapyramidal symptoms 49 anthropometric measures 49 platelet reactivity 49 EDSS score 49 transcranial Doppler 49 VerifyNow 49 Corus CAD 49 nulliparous women 49 Multicenter AIDS 49 Score DAS# 49 enteroviral infection 49 Visual Analogue Scale 49 binary logistic regression 49 antibody titer 49 System IPSS 49 electrocardiograms ECG 49 Quotient TM 49 Ankle Brachial Index 49 serum sodium levels 49 Pearson correlation coefficients 49 Fasting glucose 49 subclinical hyperthyroidism 49 carotid intima media 49 Seattle Angina Questionnaire 49 symptomatic intracranial 49 chi squared 49 handgrip strength 49 angiographically 49 d dimer 49 endometrial thickness 49 non squamous histology 49 symptomatic VTE 49 juvenile idiopathic arthritis JIA 49 clinico pathological 49 #/#mmHg 49 CP CPPS 49 thyrotropin levels 49 MetS 49 Score TOS 49 Anxiety Scale 49 Digital Mammographic Imaging 49 systolic dysfunction 49 adenoma recurrence 49 ratio WHR 49 prevalences 49 Coronary artery calcification 49 Polysomnography 49 sociodemographic factors 49 periprocedural 49 carotid artery blockage 49 p = .# [002] 49 preintervention 49 Neurological Diseases 49 GERD symptom 49 Key secondary endpoints 49 urinary albumin 49 alanine aminotransferase ALT 49 highest tertile 49 diagnosing coronary artery 49 Study AREDS 49 Framingham Offspring 49 HbA1C 49 Assessment Scale 49 alteplase 49 hours postdose 49 Secondary endpoints 49 Reynolds Risk Score 49 Urogenital Distress Inventory 49 cardiac troponin 49 postop 49 urine albumin 49 arterial thromboembolic events 49 HIV HCV coinfected 49 Histologic 49 homocysteine concentrations 49 baseline HbA1c 49 perceptual reasoning 49 D dimer 49 nonsignificant 49 ankle brachial index 49 ‰ ¥ 49 haemorrhagic strokes 49 apnea hypopnea 49 urodynamic parameters 49 μg dl 49 overnight polysomnography 49 Pharmacoeconomic 49 Impressions Improvement 49 Main Outcome Measure 49 Abnormal Involuntary Movement 49 glycosylated hemoglobin HbA1c 49 interobserver 49 Logistic regression 49 BPRS 49 statistically significant predictor 49 Confidence Interval 49 CPAP adherence 49 exhaled nitric oxide eNO 49 asymptomatic PAD 49 urate levels 49 INVEGA ® 49 = #.#-#.# 49 Dyspnea 49 Multiple logistic regression 49 lipoprotein levels 49 APOE genotype 49 transcranial Doppler ultrasound 49 limiting generalizability 49 nonfatal MI 49 multiple linear regression 49 Angiographic 49 obstructive coronary 49 Main Outcome Measures 49 Arterial Hypertension 49 attain statistical significance 49 ACR Pedi 49 posttest 49 tumor histology 49 Fasting plasma glucose 48 hs CRP 48 GH deficiency 48 epoetin alpha 48 SELENA SLEDAI score 48 serologically active patients 48 postoperative AF 48 UPDRS scores 48 serum IGF 48 nonmetastatic 48 bronchopulmonary dysplasia 48 Univariate 48 multivariable Cox 48 biochemical recurrence 48 clot busting therapy 48 PROTECT II 48 hematopoietic cancers 48 secondary efficacy endpoint 48 Framingham Risk Score 48 aneurysmal subarachnoid hemorrhage 48 Systems HCAHPS 48 carotid artery stenosis 48 Haptoglobin 48 clinically insignificant 48 hypertensives 48 HeartScore 48 arterial calcification 48 urinary albumin excretion 48 diagnosing ADHD 48 ASIA Impairment 48 baseline PASI 48 hemoglobin A1C 48 clinicopathological 48 PCWP 48 Atkins dieters cardiovascular 48 neurocognitive function 48 myocardial infarction MI 48 ETDRS 48 nadroparin 48 CORE OM 48 transient elastography 48 receiving concomitant corticosteroids 48 â ‰ ¥ 48 mean baseline A1C 48 methacholine challenge 48 HIV tropism 48 thromboembolic complications 48 genomewide 48 InSync Sentry 48 impaired fasting glucose 48 Elias Zerhouni MD 48 confounder 48 arterial oxygen saturation 48 Univariate analysis 48 dose Iluvien 48 thiazide 48 coronary revascularization 48 Integrative Biosystems Research 48 intact parathyroid hormone 48 Coronary Artery Calcium 48 liver histology 48 nonobese 48 convergent validity 48 elevated ALT 48 rhinoconjunctivitis 48 variance ANOVA 48 tertile 48 Viral load 48 Bayley Scales 48 LDL HDL 48 non affective psychosis 48 colorectal adenoma 48 CCyR 48 Clinical Practice Guideline 48 ALSFRS R 48 postintervention 48 MDRD equation 48 nonvertebral fracture 48 Cardiorespiratory fitness 48 Scale CNS 48 activated partial thromboplastin 48 noncardiac 48 Epidemiologic Studies Depression 48 Index CDAI score 48 venous thromboembolic disease 48 corrected QT interval 48 longitudinal cohort study 48 tachyarrhythmias 48 underwent liver transplantation 48 silent ischemia 48 specific antigen PSA 48 fasting glucose levels 48 MDRD 48 QoL 48 microsatellite instability 48 function subscale 48 Obsessive Compulsive Scale 48 MADIT CRT trial 48 perfusion CT 48 affective psychoses 48 cerebral oxygen saturation 48 NSQIP 48 Prostate specific antigen 48 arterial elasticity 48 sociodemographic characteristics 48 postoperative mortality 48 Nephrogenic 48 GWTG 48 Multivariate logistic regression 48 PEPI 48 demonstrated clinically meaningful 48 NYHA 48 elevated fasting glucose 48 dysthymia 48 univariate 48 IIEF 48 seropositivity 48 mm Hg systolic 48 PASI scores 48 LVSD 48 Bone density 48 URTI 48 CIBIC plus 48 systolic diastolic 48 atherogenic dyslipidemia 48 Neuropsychological 48 tissue oxygenation 48 Psychosomatic Research 48 Postoperative complications 48 Cystic Fibrosis Questionnaire Revised 48 mmHg diastolic 48 baseline FEV 48 Kidney Disease Outcomes 48 Program NCEP 48 SORT OUT III 48 prespecified 48 serum estradiol 48 recurrent wheeze 48 Doppler echocardiography 48 ipsilateral stroke 48 ASCUS 48 hemodynamic measurements 48 virological response 48 timepoints 48 albumin excretion 48 tic severity 48 nationally normed test 48 logistic regression model 48 intraclass correlation coefficients 48 urolithiasis 47 multi infarct dementia 47 RE LY 47 mIU L 47 hyperacute 47 triacylglycerol concentrations 47 regression coefficient 47 obstructive CAD 47 Renal dysfunction 47 undergoing CABG 47 Cronbach alpha 47 intraclass correlation coefficient 47 multivariable analyzes 47 Diastolic 47 abdominal circumference 47 Functioning GAF 47 cardiac autonomic 47 #.#/#.# mm Hg [001] 47 multivariate regression analysis 47 HbA1c levels 47 eGFR 47 left ventricular diastolic 47 Glomerular Filtration Rate 47 nonsignificant difference 47 Score IPSS 47 premorbid 47 SLE Responder Index 47 moderate renal impairment 47 aminotransferase ALT 47 fasting glucose 47 ADHD Rating Scale 47 univariate analyzes 47 neurodevelopmental outcome 47 abnormal lipids 47 psychiatric comorbidities 47 subthreshold depression 47 Pharmacogenetic 47 acetabular dysplasia 47 fasting insulin 47 capillary density 47 CSF biomarkers 47 creatinine clearance 47 macrovascular disease 47 mcg QD 47 overt hypothyroidism 47 Cholesterol Levels SPARCL 47 systolic pressure 47 Hachinski 47 Subgroup analysis 47 #OHD levels 47 Recurrent Stroke 47 cardioembolic stroke 47 Resolute stent 47 atherothrombotic disease 47 gadolinium enhancing lesions 47 obstructive coronary artery 47 Fonarow 47 carotid artery stenting CAS 47 postoperative pulmonary 47 Nicotine Dependence 47 serum HBV DNA 47 exploratory endpoints 47 polyp recurrence 47 fluticasone salmeterol 47 serum BDNF 47 HDL cholesterol triglycerides 47 nonischemic cardiomyopathy 47 urinary sodium excretion 47 Hb A1C 47 unpaired t 47 valvular disease 47 WAIS III 47 coronary artery calcification 47 mean ± SEM 47 hip BMD 47 Complicated Grief 47 vascular cognitive impairment 47 ARVD 47 glycosylated hemoglobin levels 47 subsyndromal 47 STRIDE PD 47 Genant modified Sharp 47 EDSS 47 pain subscale 47 c reactive protein 47 #mmHg [001] 47 interobserver agreement 47 Multivariate analysis 47 MELD score 47 artery elasticity 47 white matter hyperintensities 47 serum lipid levels 47 Symptom 47 coronary stenoses 47 statistically significant correlation 47 pulmonary dysfunction 47 spine BMD 47 habitual snorers 47 QEEG 47 Wilcoxon rank sum 47 NHANES III 47 atherosclerotic renal artery stenosis 47 prospective nonrandomized 47 C Reactive Protein 47 total cholesterol HDL 47 lipid profiles 47 variant angina 47 retrospective cohort 47 Female Sexual Function 47 dual endothelin receptor antagonist 47 somatic symptoms 47 Depressive Symptomatology 47 predictive validity 47 Quality Indicators 47 number NCT# ClinicalTrials.gov 47 carotid bruit 47 bivariate analysis 47 tissue oxygen saturation 47 intraventricular hemorrhage 47 prospectively stratified 47 RNFL 47 posttransplant 47 beta blocker therapy 47 eNO 47 Avandia Actos 47 SIMPADICO 47 acetabular fractures 47 refractory ischemia 47 syncopal 47 unmedicated peers 47 Complication rates 47 RECIST Response Evaluation Criteria 47 Socioeconomic status 47 nicardipine 47 NSTE ACS 47 Baseline characteristics 47 preoperatively 47 nonfatal stroke 47 Wechsler Memory 47 Healthy Eating Index 47 abdominal pain abdominal discomfort 47 repeat paracentesis 47 schizophreniform disorder 47 primary aldosteronism 47 serum bilirubin 47 latent celiac disease 47 familial aggregation 47 % Confidence Interval 47 CHD coronary 47 Technology NITs 47 VTE prophylaxis 47 dyslipidaemia 47 Insulin sensitivity 47 serum ferritin 47 -#.# log# copies mL 47 T1a 47 CYP#D# inhibitor 47 cerebral vasospasm 47 estimated glomerular filtration 47 % CI #.#-#.# [008] 47 Functioning Scale 47 Kruskal Wallis 47 PCA3 scores 47 sustained ventricular tachycardia 47 HbA1C levels 47 EORTC QLQ C# 47 HORIZONS AMI trial 47 CT perfusion 47 herpes zoster infection 47 comorbid depression 47 haematologic 47 impaired glucose metabolism 47 μg dL 47 sociodemographic variables 47 polysomnography 47 BMI waist circumference 47 noncardiovascular 47 neurologic abnormalities 47 cytogenic 47 Depression Rating Scale 47 depressive symptoms 47 #.#/#.# mmHg [001] 47 ACE Inhibitor 47 nondiabetic 47 drotrecogin alfa activated 47 reactogenicity 47 nondepressed 47 P ≤ 47 Cytogenetic 47 Psychiatric Epidemiology 47 serum parathyroid hormone 47 accelerometry 47 aminotransferase 47 aspartate aminotransferase AST 47 bioavailable testosterone 47 concomitant medications 47 statistically significant 47 immunochemical fecal occult 47 Atopic Dermatitis 47 laboratory abnormalities 47 Distinguished Hospitals 47 oxygen saturations 47 Pediatric Sleep 47 Pearson correlation coefficient 47 ejection fractions 47 Severe Asthma 47 retrospective cohort study 47 Cardiotoxicity 47 ATACAND 47 Kruskal Wallis test 47 APGAR 47 adiponectin concentrations 46 Endarterectomy 46 RNFL thickness 46 Pain Intensity 46 sd = 46 2 diabetes T2D 46 Claudication 46 #.#ng/ml 46 cerebrovascular accidents 46 deCODE AF TM 46 Hamilton Anxiety Scale 46 Renal Cell Carcinoma RCC 46 Charlson comorbidity index 46 sagittal abdominal diameter 46 PROLARIS 46 electroencephalographic 46 Neuroticism 46 periprocedural MI 46 #ng/ml 46 carotid artery intima media 46 Uncontrolled hypertension 46 airway hyperresponsiveness 46 GIK infusion 46 #mg/day [001] 46 intravenous thrombolysis 46 cardiac magnetic resonance 46 Hemoglobin A1C 46 thrombophilia 46 Respiratory Symptoms 46 SBM frequency 46 cortex thickness 46 quantitative EEG 46 aspartate aminotransferase 46 Persistent Sleep 46 confidence intervals CIs 46 waist circumference WC 46 NCEP ATP III 46 FluCAM arm 46 decompensated heart failure 46 cirrhotic patients 46 nocturnal hypoglycemia 46 endoscopic remission 46 6MWT 46 neurocognitive impairment 46 NHAMCS 46 serum triglyceride 46 achieved statistical significance 46 Glucosamine Chondroitin Arthritis 46 FeNO 46 EDEMA3 trial 46 SEER registries 46 glaucomatous 46 left ventricular systolic 46 electrocardiographic 46 oral anticoagulation 46 APOE e4 46 Functional Outcomes 46 serum urate 46 dexamethasone suppression 46 FDG PET scan 46 normotensive 46 umbilical artery 46 Getzenberg 46 Depressive Symptoms 46 diabetes mellitus hypertension 46 adjunctive placebo 46 #q#.# deletion syndrome 46 Eugene Braunwald 46 PD2i ® 46 fetal aneuploidy 46 interquartile range IQR 46 Osteopenia 46 preterm neonates 46 perceived exertion 46 nuchal translucency 46 KDOQI 46 Clinical Bioethics 46 Cognitive Abilities 46 nonalcoholic fatty liver 46 gastric cardia 46 diabetic polyneuropathy 46 premenopause 46 functional MRI fMRI 46 secondary endpoint 46 subclinical disease 46 Ejection Fraction 46 perioperatively 46 hippocampal volumes 46 aspirin clopidogrel 46 ARB telmisartan 46 tracheal intubation 46 recurrent atrial fibrillation 46 arteries dilate 46 urinary cortisol 46 cognitive affective 46 Global Impressions Severity 46 confidence interval #.#-#.# 46 postoperative atrial fibrillation 46 Translational Science Award 46 SSRI SNRI 46 atherothrombotic 46 QRS duration 46 Tasigna prolongs 46 CIMZIA TM certolizumab pegol 46 stone formers 46 Hb A1c 46 AST ALT 46 antiphospholipid antibodies 46 correlation coefficients 46 logistic regression models 46 inhospital mortality 46 serum cortisol 46 SSRI citalopram 46 histologic subtype 46 Complications Trial 46 comorbidity 46 PLX STROKE targeting 46 hepatic lesions 46 alanine aminotransferase 46 HER2 expression 46 #OHD 46 thrombo embolism 46 hyperhomocysteinemia 46 Neurobehavioral 46 acute myocardial infarction MI 46 non fasting triglycerides 46 Sociodemographic 46 glulisine 46 creatine kinase MB 46 microalbuminuria 46 Mandometer 46 desvenlafaxine succinate 46 systolic blood pressures 46 venous thrombotic events 46 BARACLUDE r 46 β = 46 inhibin 46 IELT 46 comorbidities 46 prolonged QT interval 46 hemorrhagic complications 46 Suboptimal 46 serum creatinine levels 46 RE LY trial 46 isolated systolic hypertension 46 mm Hg diastolic 46 Meta analyzes 46 AG# [005] 46 Orthostatic Hypotension 46 CrCl 46 microalbumin 46 Excessive daytime sleepiness 46 Coronary Artery Bypass Graft 46 Carotid Endarterectomy 46 multivariate analyzes 46 non menstrual pelvic 46 Hypertrophy 46 A1c levels 46 T2 lesions 46 prehypertensive 46 NIS LL 46 GBA mutations 46 body fatness 46 underwent CABG 46 mg BID dose 46 Histopathological 46 Lewis Kuller 46 6MWD 46 PSADT 46 Comorbidities 46 cryptogenic stroke 46 ischemic cardiomyopathy 46 BPS IC 46 unipolar depression 46 non valvular atrial 46 prospective multicentre 46 D Dimer